Voloridge Investment Management
TGTX icon

Voloridge Investment Management’s TG Therapeutics TGTX Stock Holding History

Voloridge Investment Management’s Portfolio TGTX Stock Details TGTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-560,727
Closed -$16.7M – 1282
2025
Q4 		$16.7M Buy
560,727
+347,821
+163% +$11.4M 0.06% 418
2025
Q3 		$7.69M Buy
+212,906
New +$7.01M 0.03% 623
2025
Q2 		– Sell
-188,776
Closed -$7.44M – 1372
2025
Q1 		$7.44M Buy
+188,776
New +$6.35M 0.03% 667
2023
Q4 		– Sell
-1,612,534
Closed -$13.5M – 1468
2023
Q3 		$13.5M Buy
1,612,534
+958,954
+147% +$13.4M 0.07% 379
2023
Q2 		$16.2M Sell
653,580
-559,959
-46% -$14.5M 0.08% 341
2023
Q1 		$18.3M Buy
1,213,539
+34,066
+3% +$517K 0.09% 308
2022
Q4 		$14M Buy
1,179,473
+375,104
+47% +$2.72M 0.08% 343
2022
Q3 		$4.76M Sell
804,369
-79,947
-9% -$524K 0.03% 667
2022
Q2 		$3.76M Sell
884,316
-241,007
-21% -$1.5M 0.02% 783
2022
Q1 		$10.7M Buy
1,125,323
+668,197
+146% +$7.73M 0.06% 395
2021
Q4 		$8.69M Buy
+457,126
New +$11.9M 0.05% 510
2021
Q1 		– Sell
-41,814
Closed -$2.17M – 1660
2020
Q4 		$2.17M Buy
+41,814
New +$1.41M 0.02% 708
2020
Q2 		– Sell
-34,846
Closed -$343K – 1493
2020
Q1 		$343K Buy
34,846
+12,277
+54% +$155K 0.01% 824
2019
Q4 		$251K Buy
+22,569
New +$172K ﹤0.01% 966

Other funds holding TGTX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Voloridge Investment Management's TGTX Position: Q1 2026 in Review

Voloridge Investment Management sold out of TG Therapeutics (TGTX) in Q1 2026, closing a stake of 560,727 shares — an estimated $16.7M sold.

Voloridge Investment Management first reported a position in TGTX in Q4 2019 and held it in 14 quarters. The position peaked at $18.3M in Q1 2023. 364 funds tracked by Wall St. Rank hold TGTX as of Q1 2026.

  • Voloridge Investment Management reported no remaining TG Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Voloridge Investment Management sold 560,727 TG Therapeutics shares in Q1 2026, an estimated $16.7M.
  • Voloridge Investment Management first reported a position in TG Therapeutics in Q4 2019 and held it in 14 quarters.
  • Voloridge Investment Management's TG Therapeutics position peaked at $18.3M in Q1 2023.
  • 364 funds tracked by Wall St. Rank held TG Therapeutics as of Q1 2026.

Based on Voloridge Investment Management's 13F filing for Q1 2026, filed 15 May 2026.